Skip to main content
Medacta Group SA logo

Medacta Group SA — Investor Relations & Filings

Ticker · MOVE ISIN · CH0468525222 LEI · 506700P2PFU3A3DROC14 SW Manufacturing
Open in API
Filings indexed 197 across all filing types
Latest filing 2024-08-28 Regulatory Filings
Country CH Switzerland
Listing SW MOVE

About Medacta Group SA

https://www.medacta.com/

Medacta Group SA is a medical device company that designs, manufactures, and distributes orthopaedic and neurosurgical products worldwide. Its portfolio focuses on joint replacement, spine surgery, and sports medicine. The company emphasizes innovation in minimally invasive surgical techniques and personalized patient solutions, developed through close collaboration with surgeons. A key component of its business model is the M.O.R.E. Institute, a global medical education platform that provides comprehensive training and support for healthcare professionals. Medacta is recognized for pioneering advanced surgical approaches, such as Kinematic Alignment for total knee replacement, with a focus on improving patient outcomes and healthcare sustainability.

Recent filings

Filing Released Lang Actions
Mighty Oak Medical and Medacta Announce Non-Exclusive Worldwide License of Patents for Patient-Specific Pedicle Screw Guides
Regulatory Filings Classification · 1% confidence The document is a 'MEDIA RELEASE' dated August 28, 2024, announcing a settlement and non-exclusive worldwide license agreement between Mighty Oak Medical and Medacta regarding patent disputes for patient-specific pedicle screw guides. This type of announcement, detailing a specific business event (licensing agreement, litigation resolution) that is not a standard periodic financial report (like 10-K, IR, ER), typically falls under general regulatory announcements or news releases. Since there is no specific category for 'Business/Legal Settlement Announcement' and it is not a standard financial filing, it best fits the 'Regulatory Filings' (RNS) category, which serves as a general regulatory announcement fallback for miscellaneous, material, non-financial disclosures. The document length is short (3937 chars) and it is a direct announcement, not a report itself.
2024-08-28 English
Medacta Group SA: Medacta Group SA revenues grew 14.3% at constant currency in 1H 2024
Earnings Release Classification · 1% confidence The document is titled 'Medacta Group SA revenues grew 14.3% at constant currency in 1H 2024' and explicitly states it is a 'Press Release – Ad-hoc announcement pursuant to Art. 53 LR'. It provides preliminary, unaudited revenue figures for the first half (1H) of 2024, detailing sales performance by geography and product line. This content aligns perfectly with an Earnings Release (ER), which is the initial announcement of periodical financial results (key highlights only). Although it mentions the full '2024 Half Year Results' will be announced later (September 25, 2024), this specific document serves as the preliminary top-line announcement, making ER the most appropriate classification over the comprehensive Interim Report (IR). H1 2024
2024-07-24 English
Medacta Group SA: Medacta Group SA revenues grew 14.3% at constant currency in 1H 2024
Earnings Release Classification · 1% confidence The document is explicitly titled as an "Ad hoc announcement pursuant to Art. 53 LR" and a "Press Release". It provides preliminary, unaudited revenue figures for the first half of 2024 (1H 2024) and announces that the full '2024 Half Year Results' will be released on September 25, 2024. Since this document only contains the initial, high-level revenue highlights and schedules the release of the comprehensive report, it fits the definition of an Earnings Release (ER), which covers the initial announcement of periodical financial results (key highlights only). It is not the full Interim/Quarterly Report (IR) because it states the full results are coming later, nor is it a Report Publication Announcement (RPA) because it contains substantive financial data, not just a notice that a report is available. H1 2024
2024-07-24 English
Medacta 25th Anniversary World Tour continues with events in Australia and the United States focusing on Personalized and Sustainable Total Knee Arthroplasty
Regulatory Filings Classification · 1% confidence The document is a 'MEDIA RELEASE' dated May 30, 2024, announcing upcoming scientific events (symposiums/summits) related to Medacta's 25th anniversary and focusing on knee arthroplasty technology. It is not a formal regulatory filing like a 10-K, IR, or ER, nor is it a transcript (CT) or a specific financial report (AR, FS, IR). It is an announcement about company activities, scientific education, and product focus, which fits best under a general announcement category. Since it is a news release detailing corporate activities and events rather than a specific financial report or mandatory filing, and it doesn't fit other specific categories like DIRS, DIV, or MANG, the most appropriate classification is Regulatory Filings (RNS) as a general regulatory announcement/press release, or potentially a Report Publication Announcement (RPA) if it were announcing the publication of a formal report, which it is not—it announces events. Given the content is a press release about ongoing business activities and events, RNS (Regulatory Filings/General Announcement) is the most suitable fallback, although it is essentially a press release.
2024-05-30 English
Medacta 25th Anniversary World Tour continues with events in Australia and the United States focusing on Personalized and Sustainable Total Knee Arthroplasty
Regulatory Filings Classification · 1% confidence The document is a press release dated May 30, 2024, announcing upcoming scientific events (symposiums and summits) related to Medacta's 25th anniversary and focusing on knee arthroplasty techniques. It details event locations, dates, and scientific focus areas, quoting the CEO and other experts. This is not a formal regulatory filing like a 10-K, an earnings release (ER), or a quarterly report (IR). It is an announcement about company activities, specifically scientific/educational events, which falls under general corporate communication. Since there is no specific category for 'Event Announcement' or 'Press Release', and it is not a management change (MANG), director dealing (DIRS), or dividend notice (DIV), the most appropriate fallback category is Regulatory Filings (RNS) for miscellaneous, non-standard corporate announcements, although it is primarily a marketing/PR communication.
2024-05-30 English
Medacta announces the results of today's Annual General Meeting
AGM Information Classification · 1% confidence The document explicitly states in the title and body that it announces the 'results of today’s Annual General Meeting' (AGM). It details the approval of proposals, dividend distribution, and re-election of board members. This content directly corresponds to the purpose of an AGM results announcement. While it mentions the approval of the Annual Statutory Financial Statements, the primary focus and context of the release is the meeting outcome itself. Therefore, the most appropriate classification is AGM Information (AGM-R).
2024-05-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.